The University of Southampton
University of Southampton Institutional Repository

Structure led drug design for the pentraxins

Structure led drug design for the pentraxins
Structure led drug design for the pentraxins

Serum Amyloid P component (SAP) and C-reactive protein (CRP) are members of the ‘short’ pentraxin sub-family and are composed of five identical subunits arranged symmetrically around a central, hollow pore.

CPHPC, the ligand targeted specifically at SAP, consists of two proline residues joined by a six carbon linker and was identified using the Roche compound library. Crystals of SAP in complex with CPHPC were grown in novel crystallisation conditions and diffracted X-rays to a resolution of 1.6 Ǻ. The three-dimensional structure of the complex reveals the formation of an SAP decamer consisting of two molecules of SAP linked by five CPHPC molecules. The peptide bond in the proline residues of the CPHPC molecules can exist in either cis or trans conformation. The identification of the preferred conformation in the CPHPC molecule could potentially increase the potency of the drug in its inhibition of SAP binding to amyloid deposits. The 1.6 Ǻ structure of the SAP-CPHPC suggests that the cis conformation is the preferred state of the proline peptide bond in CPHPC.

PCHPC, the ligand targeted at CRP, was created using the rational drug-design approach and is composed of two phosphocholine residues (the natural ligand of CRP) joined by a six carbon linker. The structure of the CRP-PCHPC complex reveals an identical decamer to that formed by the SAP-PCHPC complex with five PCHPC molecules linking two CRP molecules.

Alternative approaches to drug design for both SAP and CRP are available that may improve the potency of CPHPC and PCHPC. Multivariate ligands have been designed for both the Shiga-like and cholera toxins and have been shown to improve binding affinities with respect to their monovalent equivalents.

University of Southampton
Jenvey, Michelle Catherine
6d554856-5f4a-4702-b76d-5a0770c5fc4f
Jenvey, Michelle Catherine
6d554856-5f4a-4702-b76d-5a0770c5fc4f

Jenvey, Michelle Catherine (2006) Structure led drug design for the pentraxins. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Serum Amyloid P component (SAP) and C-reactive protein (CRP) are members of the ‘short’ pentraxin sub-family and are composed of five identical subunits arranged symmetrically around a central, hollow pore.

CPHPC, the ligand targeted specifically at SAP, consists of two proline residues joined by a six carbon linker and was identified using the Roche compound library. Crystals of SAP in complex with CPHPC were grown in novel crystallisation conditions and diffracted X-rays to a resolution of 1.6 Ǻ. The three-dimensional structure of the complex reveals the formation of an SAP decamer consisting of two molecules of SAP linked by five CPHPC molecules. The peptide bond in the proline residues of the CPHPC molecules can exist in either cis or trans conformation. The identification of the preferred conformation in the CPHPC molecule could potentially increase the potency of the drug in its inhibition of SAP binding to amyloid deposits. The 1.6 Ǻ structure of the SAP-CPHPC suggests that the cis conformation is the preferred state of the proline peptide bond in CPHPC.

PCHPC, the ligand targeted at CRP, was created using the rational drug-design approach and is composed of two phosphocholine residues (the natural ligand of CRP) joined by a six carbon linker. The structure of the CRP-PCHPC complex reveals an identical decamer to that formed by the SAP-PCHPC complex with five PCHPC molecules linking two CRP molecules.

Alternative approaches to drug design for both SAP and CRP are available that may improve the potency of CPHPC and PCHPC. Multivariate ligands have been designed for both the Shiga-like and cholera toxins and have been shown to improve binding affinities with respect to their monovalent equivalents.

Text
1043850.pdf - Version of Record
Available under License University of Southampton Thesis Licence.
Download (5MB)

More information

Published date: 2006

Identifiers

Local EPrints ID: 466130
URI: http://eprints.soton.ac.uk/id/eprint/466130
PURE UUID: 62150387-015e-4ae0-ada1-0e9e6842c55b

Catalogue record

Date deposited: 05 Jul 2022 04:26
Last modified: 16 Mar 2024 20:31

Export record

Contributors

Author: Michelle Catherine Jenvey

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×